Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 1,132,662 Less Arrow 905,437 Less Arrow 609,582
Financial expenses 126,459 Less Arrow 71,279 More Arrow 77,172
Earnings before taxes -103,857 More Arrow 83,576 Less Arrow 32,609
EBITDA 134,405 More Arrow 232,951 Less Arrow 186,814
Total assets 2,414,160 Less Arrow 2,225,862 Less Arrow 1,537,992
Current assets 747,717 Less Arrow 586,907 Less Arrow 345,436
Current liabilities 397,244 Less Arrow 335,748 Less Arrow 169,468
Equity capital 866,726 Less Arrow 830,163 Less Arrow 659,251
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 69 More Arrow 88 Less Arrow 69

Financial ratios

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 35.9% More Arrow 37.3% More Arrow 42.9%
Turnover per employee 16,415 Less Arrow 10,289 Less Arrow 8,835
Profit as a percentage of turnover -9.2% More Arrow 9.2% Less Arrow 5.3%
Return on assets (ROA) 0.9% More Arrow 7.0% More Arrow 7.1%
Current ratio 188.2% Less Arrow 174.8% More Arrow 203.8%
Return on equity (ROE) -12.0% More Arrow 10.1% Less Arrow 4.9%
Change turnover
Change turnover % 49% Less Arrow 23%
Chg. No. of employees
Chg. No. of employees % 28% More Arrow 33%

Total value of public sale

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.